Stimulus-Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy

206Citations
Citations of this article
162Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Deregulated inflammations induced by various factors are one of the most common diseases in people's daily life, while severe inflammation can even lead to death. Thus, the efficient treatment of inflammation has always been the hot topic in the research of medicine. In the past decades, as a potential biomaterial, stimuli-responsive hydrogels have been a focus of attention for the inflammation treatment due to their excellent biocompatibility and design flexibility. Recently, thanks to the rapid development of nanotechnology and material science, more and more efforts have been made to develop safer, more personal and more effective hydrogels for the therapy of some frequent but tough inflammations such as sepsis, rheumatoid arthritis, osteoarthritis, periodontitis, and ulcerative colitis. Herein, from recent studies and articles, the conventional and emerging hydrogels in the delivery of anti-inflammatory drugs and the therapy for various inflammations are summarized. And their prospects of clinical translation and future development are also discussed in further detail.

Cite

CITATION STYLE

APA

Yu, H., Gao, R., Liu, Y., Fu, L., Zhou, J., & Li, L. (2024, January 5). Stimulus-Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy. Advanced Science. John Wiley and Sons Inc. https://doi.org/10.1002/advs.202306152

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free